Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials

Differences between treatment groups in organ dysfunction in RCTs in septic shock occur despite lack of mortality differences depending on calculation method. If standardized and validated further, DAF could become the primary endpoint of RCTs in septic shock.